Dr. Hamed is the Global Head of Medical for Rare Disease. Alaa and his team are responsible for expanding the strong legacy of Medical Leadership in Sanofi Rare Disease, focusing on new evidence generation strategies, providing medical insights to product development, and ensuring effective and meaningful Medical engagement with Rare Disease stakeholders around the world.
With a central focus on patient outcomes, and in strong partnerships with external experts and stakeholders, he has spearheaded the development of numerous innovative disease-specific clinical outcome assessments, while regularly representing the company in multiple congress, industry, regulatory, and HTA interactions. Dr. Hamed has been with Sanofi for more 12 years, prior to that he held various positions in Academia and biotech in HEOR, Medical, Clinical, Regulatory, and Health Services Research.
His research has resulted in numerous high-impact publications authored in collaboration with key external experts, and he serves as a reviewer for multiple journals. He holds an MD from Cairo University and both and MBA and MPH from Boston University.
